Form 8.5 (EPT/RI) - Mediclinic International – Company Announcement

Form 8.5 (EPT/RI) - Mediclinic International

Jul 04 2022 12:26 BSTSource: RNS

RNS Number : 2127R

UBS AG (EPT)

04 July 2022

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the Code)

1. KEY INFORMATION

(a) Name of exempt principal trader:	UBS Investment Bank, London
(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree	Mediclinic International plc
(c) Name of the party to the offer with which exempt principal trader is connected:	Mediclinic International plc
(d) Date dealing undertaken:	01 July 2022
(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer? If it is a cash offer or possible cash offer, state "N/A"	NO

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchases/ sales

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

10p ordinary

Buy

415384

4.57800 GBP

4.44894 GBP

10p ordinary

Sell

313806

4.57800 GBP

4.45899 GBP

(b) Cash-settled derivative transactions

Class of relevant security	Product description e.g. CFD	Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position	Number of reference securities	Price per unit
10p ordinary	CFD	Long	28	4.511929 GBP
10p ordinary	CFD	Long	941	4.507384 GBP
10p ordinary	CFD	Long	2001	4.532 GBP
10p ordinary	CFD	Long	1309	4.52335 GBP
10p ordinary	CFD	Long	25137	89.10162669 ZAR
10p ordinary	CFD	Long	15927	89.15401457 ZAR
10p ordinary	CFD	Long	33645	88.55723287 ZAR
10p ordinary	CFD	Long	42	4.494 GBP
10p ordinary	CFD	Long	221	4.52555669683258 GBP
10p ordinary	CFD	Long	27125	4.578 GBP
10p ordinary	CFD	Long	108	4.52158484 GBP
10p ordinary	CFD	Long	2685	4.531909 GBP
10p ordinary	CFD	Long	13176	4.526596 GBP
10p ordinary	CFD	Long	4510	4.50378772 GBP
10p ordinary	CFD	Long	10993	4.514596 GBP
10p ordinary	CFD	Long	4320	4.525027 GBP
10p ordinary	CFD	Short	27125	4.578 GBP
10p ordinary	CFD	Short	1266	4.52120063191153 GBP
10p ordinary	CFD	Short	28	4.53206798 GBP
10p ordinary	CFD	Short	21000	4.53688333333333 GBP
10p ordinary	CFD	Short	1631	4.548731 GBP
10p ordinary	CFD	Short	394	4.49823 GBP
10p ordinary	CFD	Short	17944	88.5640158270174 ZAR
10p ordinary	CFD	Short	21704	4.532 GBP
10p ordinary	CFD	Short	15701	88.5494809247819 ZAR
10p ordinary	CFD	Short	15927	89.15401457 ZAR
10p ordinary	CFD	Short	25137	89.10162669 ZAR
10p ordinary	CFD	Short	62	4.544091 GBP
10p ordinary	CFD	Short	400	4.512215 GBP
10p ordinary	CFD	Short	3570	4.535648 GBP
10p ordinary	CFD	Short	177	4.512802 GBP
10p ordinary	CFD	Short	8693	4.509321 GBP
10p ordinary	CFD	Short	4152	4.518934 GBP
10p ordinary	CFD	Short	610	4.509302 GBP

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none "

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

Date of disclosure:	04 July 2022
Contact name:	Richard Howard
Telephone number:	+44 (0)207 568 9128

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

FERZZGGNGDKGZZM

Company Announcements

Form 8.5 (EPT/RI) - Mediclinic International

Date of disclosure:

Contact name:

Telephone number: